Axial Reade Capital

About The Fund

Axial Reade Capital, operating under the banner of Foundation Venture Capital Group, is a venture capital firm focused on impact investing in New Jersey's burgeoning health-related technology industry. They specialize in providing pre-seed and seed funding to innovative start-up companies with potentially transformative health-related ideas. Beyond financial support, they fervently support the start-ups at affiliated organizations by offering strategic business guidance and operational support. Their extensive assistance covers a wide spectrum of services from before the incorporation of the start-up, extending throughout the company's lifecycle, and potentially until traditional venture capital can be secured for further development and commercialization. They invest with the objective of generating positive, measurable social impact, which is paramount to their mission. The gains they realize from their investments are reinvested back into research and innovation at their affiliated organizations, representing a cyclical reinforcement of their core thesis. Foundation Venture Capital Group takes pride in enabling researchers to take their viable research from the laboratory into marketable solutions that eventually reach patients, offering new products, services, and treatments that can make significant health impacts. They are part of a family of companies, alongside Foundation for Health Advancement and New Jersey Health Foundation, which are collectively dedicated to nurturing health-related innovation in the New Jersey area. They offer a continuum of funding and also provide various grant programs through their related companies for early research with exciting potential and for addressing community health issues. Another aspect of their commitment to health-related innovation is providing innovation grants for middle and high school STEM programs, thereby fostering the next generation of research and development in New Jersey.